CD274 and neoplasm: Recent evidence implies triple-negative breast cancer (TNBC) may also be susceptible to immunotherapy: it shows high mutational load among breast cancers, expression of checkpoint molecules such as PD-L1, and infiltration of immune cells suggestive of pre-existing immunity towards tumor.